OM GROUP INC
10-Q, EX-27, 2000-11-14
INDUSTRIAL INORGANIC CHEMICALS
Previous: OM GROUP INC, 10-Q, EX-15.2, 2000-11-14
Next: MYRIAD GENETICS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE OM
GROUP, INC. CONDENSED CONSOLIDATED BALANCE SHEET AT SEPTEMBER 30, 2000
(UNAUDITED) AND THE OM GROUP, INC. CONDENSED STATEMENT OF CONSOLIDATED INCOME
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2000 (UNAUDITED) AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-END>                               SEP-30-2000             SEP-30-2000
<CASH>                                          15,713                  15,713
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  138,486                 138,486
<ALLOWANCES>                                         0                       0
<INVENTORY>                                    373,569                 373,569
<CURRENT-ASSETS>                               614,457                 614,457
<PP&E>                                         592,551                 592,551
<DEPRECIATION>                                 135,124                 135,124
<TOTAL-ASSETS>                               1,307,915               1,307,915
<CURRENT-LIABILITIES>                          151,760                 151,760
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                           240                     240
<OTHER-SE>                                     489,219                 489,219
<TOTAL-LIABILITY-AND-EQUITY>                 1,307,915               1,307,915
<SALES>                                        233,384                 655,191
<TOTAL-REVENUES>                               233,384                 655,191
<CGS>                                          176,554                 500,959
<TOTAL-COSTS>                                  195,855                 553,709
<OTHER-EXPENSES>                                 (633)                 (1,379)
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              11,677                  28,722
<INCOME-PRETAX>                                 26,485                  74,139
<INCOME-TAX>                                     7,858                  21,934
<INCOME-CONTINUING>                             18,627                  52,205
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                    18,627                  52,205
<EPS-BASIC>                                        .78                    2.19
<EPS-DILUTED>                                      .77                    2.15


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission